Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jun 19, 2023
Date Accepted: Apr 1, 2024

The final, peer-reviewed published version of this preprint can be found here:

Machine Learning Models for Parkinson Disease: Systematic Review

Tabashum T, Snyder RC, O'Brien MK, Albert MV

Machine Learning Models for Parkinson Disease: Systematic Review

JMIR Med Inform 2024;12:e50117

DOI: 10.2196/50117

PMID: 38771237

PMCID: 11112052

A Systematic Review of Machine Learning Models for Parkinson’s Disease

  • Thasina Tabashum; 
  • Robert Cooper Snyder; 
  • Megan K. O'Brien; 
  • Mark V. Albert

ABSTRACT

Background:

With the increasing availability of data, computing resources, and easier-to-use software libraries, artificial intelligence (AI) is increasingly utilized in disease detection and prediction, including Parkinson’s Disease (PD). Despite the large number of studies published every year, very few AI systems are adopted for patient use. This review highlights the tools and techniques to minimize the gap between reported performance in research papers and the real-life applicability of machine learning models in detecting and predicting diseases such as PD.

Objective:

This review focuses on standard machine learning model reporting practices in PD prediction. Previous studies acknowledge that lack of standardization reporting and insufficient information create barriers for the research community. We synthesized the information of 113 studies to identify recurring issues or areas where reporting practice falls short. This identification allows the scientific community to recognize the specific pitfalls and can guide future efforts to enhance the reporting standard. We emphasize the importance of adhering to these practices to foster research progress and ensure the credibility use of machine learning models in real-world applications.

Methods:

We conducted a systematic review of studies in 2020 and 2021 that use machine learning models to diagnose PD or to track PD progression. Using a predefined standard query and appropriate exclusion criteria, we searched PUBMED and found 113 papers that specifically used machine learning for the classification or regression prediction of PD or PD-related symptoms.

Results:

Notable limitations include observing that only 27.4% of papers used a hold-out test set to avoid potentially inflated accuracies, and approximately half of the papers without a hold-out test set did not state this as a potential concern. Surprisingly, 38.9% of papers did not report on how or if models were tuned, and an additional 27.4% used ad hoc model tuning, which is generally frowned upon in machine learning model optimization. Only 11.5% of papers performed direct comparisons of results with other models, severely limiting the interpretation of results.

Conclusions:

These data-driven detection and prediction models perform well in publication but fail to perform in practice, which can imply modern AI methods are limited. However, this lack of external validity is primarily the result of poor practices in using machine learning, which hinders clinical adoption of AI, even for challenges that may ultimately require such data-driven machine learning approaches.


 Citation

Please cite as:

Tabashum T, Snyder RC, O'Brien MK, Albert MV

Machine Learning Models for Parkinson Disease: Systematic Review

JMIR Med Inform 2024;12:e50117

DOI: 10.2196/50117

PMID: 38771237

PMCID: 11112052

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.